Associate Director, Regional Marketing (Mid-Atlantic Region)

Philadelphia, PA (Remote)

Salary Not AvailableMid Level5+ years expFull time

Posted 1 month ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own regional KOL development, advisory programs, and market access alignment for hematology/oncology across multiple markets, driving geo targeted campaigns, congress presence, and HCP engagement with TLs and ADC therapeutics strategy.

  • Regional ownership: marketing plans, asset deployment, geo targeted media, and congress planning.
  • Stakeholder network: KOLs, TLs, and local thought leaders; advisory boards and speaker bureau coordination.
  • Collaboration and governance: cross functional account planning with hematology specialists and field leadership; TL influence mapping and regional plans.

Job Description

Responsibilities

  • Lead and execute regional marketing plans
  • Work with the Agency of Record (AOR) and home office to develop and to execute regional marketing plans including asset deployment, media execution (geo-targeting), and congress planning.
  • Identify, monitor, and report key performance metrics for the region
  • Align with cross functional matrix team on local account planning (Associate Director, Strategic Accounts, Hematology Therapeutic Specialists)
  • Identify local and regional HCPs to participate in key commercial projects including webcasts, videos, promotional materials, and training opportunities
  • Identify and develop regional and local thought leaders
  • Identifies, develops, and engages with local and regional KOLs across, Hematology/Oncology and especially within the lymphoma expert community in the region.
  • Works with Agency of Record and brand team to map regional TL influence and support regional account plan development and execution
  • Develop and execute regional advisory boards and third-party program plans
  • Identify and develop local and regional HCPs to participate in the ADC Therapeutics Speaker Bureau for ZYNLONTA and disease state programs

Requirements

  • Bachelor’s Degree required. Health care certification/qualification (e.g. RN, RPh, other) is preferred
  • 5 or more years' work experience required in the pharmaceutical or biotech industry, specifically in hematology and oncology and experience in academic settings important
  • Product launch experience in hematology or oncology
  • At least 2 years' previous direct experience with hematology thought leaders (physician and nurse) with demonstrated access to academic and key institutions
  • 2 years of experience in marketing/agency or another related in-house commercial role
  • 2+ years previous field sales or market access leadership experience in the pharmaceutical or biotech industry is preferred
  • Proven and thorough knowledge of commercial issues associated with highly competitive hematology / oncology therapeutic areas is preferred
  • Exceptional presentation, interpersonal, cross-functional collaboration, and strategic thinking skills
  • Comfort understanding and explaining complex clinical data and disease state information with internal stakeholders and external customers
  • Proven track record for consistently meeting or exceeding qualitative and /or quantitative goals
  • Experience developing strategy and executing tactics with oversight or direct management of budget
  • 40-50% domestic travel required

Preferred

  • Health care certification/qualification preferred (e.g. RN, RPh, other)
  • 2+ years previous field sales or market access leadership experience in the pharmaceutical or biotech industry is preferred
  • Proven and thorough knowledge of commercial issues associated with highly competitive hematology / oncology therapeutic areas is preferred
  • 2 years of experience in marketing/agency or another related in-house commercial role
  • Exceptional presentation, interpersonal, cross-functional collaboration, and strategic thinking skills (preferred)
ADC Therapeutics logo

ADC Therapeutics

4.1 Glassdoor

ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. We are a pioneer in the ADC field with specialized capabilities unique to ADCs from clinical to manufacturing and commercialization with a proven track record that includes an approved and marketed product. Our CD19-directed ADC ZYNLONTA® (loncastuximab tesirine-lpyl) received accelerated approval by the FDA and conditional approval from the European Commission for the treatment of relapsed or refractory diffuse large B-cell lymphoma after two or more lines of systemic therapy. ZYNLONTA is also in development in combination with other agents and in earlier lines of therapy. In addition to ZYNLONTA, ADC Therapeutics is leveraging its expertise to advance IND-enabling activities for a next-generation PSMA-targeting ADC.Founded in 2011, ADC Therapeutics is based in Lausanne, Switzerland, with operations in New Jersey. Our highly skilled global team is committed to confronting cancer with the full potential of our science and transforming the treatment paradigm for patients with cancer.For more information, please visit https://www.adctherapeutics.com/.

Founded in 2011
Lausanne, Vaud, CHE
291 employees (6 in marketing)
84% recommend to a friend
69% CEO approval

Traffic Signals

Monthly Visitors
14.4K
Traffic Source Mix
Search
28%
Direct
24.4%
Referral
4.3%
Social
3.7%
Paid
0.6%

Headcount Trend

Current headcount: ~291

Marketing Team

Marketing Team Size
6 (2% of company)

Funding

Total Funding
$1B
Last Raise
$60M
Post IPO Equity, 5 months ago

Funding History

  • Oct 2025
    Post IPO Equity • $60M
  • Jun 2025
    Post IPO Equity • $100M
  • May 2024
    Post IPO Equity • $105M

Recent News